Want to see TSE:FRX full AI Analyst Report?

Fennec Pharmaceuticals (FRX) Revenue

40 Followers

Fennec Pharmaceuticals Revenue

Fennec Pharmaceuticals had a revenue of 17.87M in the quarter ending Jun 30, 2026, with 18.31%. This bring the company's revenue in the last twelve months to 59.22M, Decreased 16.12%. In the fiscal year ending Dec 31, 2025, Fennec Pharmaceuticals had annual revenue of 44.64M with -6.09% growth.

Revenue (ttm)

59.22M

Revenue Growth

75.94%

P/S Ratio

12.08

Revenue/Employee

C$1,275,486

Employees

Market Cap

C$539.37M

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	44.64M	-2.90M	-6.09%
Dec 31, 2024	47.54M	26.29M	+123.69%
Dec 31, 2023	21.25M	19.72M	+1,284.50%
Dec 31, 2022	1.53M	―	+∞%
Dec 31, 2021	―	-170.00K	-100.00%
Dec 31, 2020	170.00K	―	+∞%
Dec 31, 2019	―	―	―
Dec 31, 2018	―	―	―
Dec 31, 2017	―	―	―